Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EV / Sales (ntm)

Arbutus Biopharma Cp EV / Sales (ntm) Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EV / Sales (ntm) from 2010 to 2018.
  • Arbutus Biopharma Cp EV / Sales (ntm) for the quarter ending March 03, 2018 was 145.73 a 93.93% increase of 136.88 year over year
  • Arbutus Biopharma Cp Annual EV / Sales (ntm) for 2015 was 3.38 a -175.88% decrease of -5.95 from 2014
  • Arbutus Biopharma Cp Annual EV / Sales (ntm) for 2014 was 9.33 a 25.93% increase of 2.42 from 2013
  • Arbutus Biopharma Cp Annual EV / Sales (ntm) for 2013 was 6.91 a 59.00% increase of 4.08 from 2012
Other Valuation Metrics:
  • Arbutus Biopharma Cp Market Cap for the quarter ending March 03, 2018 was $275m a 28.06% increase of 77m year over year
  • Arbutus Biopharma Cp Price / Book for the quarter ending March 03, 2018 was 2.07 a 49.51% increase of 1.03 year over year
  • Arbutus Biopharma Cp Enterprise Value for the quarter ending March 03, 2018 was $211m a 52.69% increase of 111m year over year
View Chart On Koyfin

Quarterly ABUS EV / Sales (ntm) Data

03/2018145.73
09/201753.23
06/201742.51
03/20178.85
09/201613.95
06/20162.63
03/20168.94
12/20153.38
09/20159.57
06/20159.62

Annual ABUS EV / Sales (ntm) Data

20153.38
20149.33
20136.91
20122.83
20110.36
20101.29